EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

A Repurposed Drug Interferes with Nucleic Acid to Inhibit the Dual Activities of Coronavirus Nsp13

Nathan Soper, Isabelle Yardumian, Eric Chen, Chao Yang iD, Samantha Ciervo, Aaron L Oom, Ludovic Desvignes, Mark J Mulligan, Yingkai Zhang iD, Tania J Lupoli iD

ACS Chemical Biology · 2024

DOI: 10.1021/acschembio.4c00244 ↗

At a glance

Journal article in ACS Chemical Biology, 2024. Written by Nathan Soper and 9 co-authors. Institution: Department of Chemistry, New York University, New York, New York 10003, United States. Major MEDLINE topics: SARS-CoV-2, Viral Nonstructural Proteins, Antiviral Agents, Drug Repositioning. Cited 19 times so far (Crossref); 65 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIAID NIH HHS, NIGMS NIH HHS, New York University.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

The recent pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) highlighted a critical need to discover more effective antivirals. While therapeutics for SARS-CoV-2 exist, its nonstructural protein 13 (Nsp13) remains a clinically untapped target. Nsp13 is a helicase responsible for unwinding double-stranded RNA during viral replication and is essential for propagation. Like other helicases, Nsp13 has two active sites: a nucleotide binding site that hydrolyzes nucleoside triphosphates (NTPs) and a nucleic acid binding channel that unwinds double-stranded RNA or DNA. Targeting viral helicases with small molecules, as well as the identification of ligand binding pockets, have been ongoing challenges, partly due to the flexible nature of these proteins. Here, we use a virtual screen to identify ligands of Nsp13 from a collection of clinically used drugs. We find that a known ion channel inhibitor, IOWH-032, inhibits the dual ATPase and helicase activities of SARS-CoV-2 Nsp13 at low micromolar concentrations. Kinetic and binding assays, along with computational and mutational analyses, indicate that IOWH-032 interacts with the RNA binding interface, leading to displacement of nucleic acid substrate, but not bound ATP. Evaluation of IOWH-032 with microbial helicases from other superfamilies reveals that it is selective for coronavirus Nsp13. Furthermore, it remains active against mutants representative of observed SARS-CoV-2 variants. Overall, this work provides a new inhibitor for Nsp13 and provides a rationale for a recent observation that IOWH-032 lowers SARS-CoV-2 viral loads in human cells, setting the stage for the discovery of other potent viral helicase modulators.

Subjects

MeSH terms (MEDLINE)

SARS-CoV-2Viral Nonstructural ProteinsAntiviral AgentsDrug RepositioningHumansRNA HelicasesCOVID-19Nucleic AcidsCOVID-19 Drug TreatmentAdenosine TriphosphatasesMethyltransferases

Substances

Viral Nonstructural ProteinsAntiviral AgentsNsp13 protein, SARS-CoVRNA HelicasesNucleic AcidsAdenosine TriphosphatasesMethyltransferases

Authors and institutions

  • Department of Chemistry, New York University, New York, New York 10003, United States.
  • Simons Center for Computational Physical Chemistry at New York University, New York, New York 10003, United States.
  • NYU Langone Vaccine Center, Department of Medicine, New York University Grossman School of Medicine, New York, New York 10016, United States.
  • High Containment Laboratories, Office of Science and Research, NYU Langone Health, New York, New York 10016, United States.

ORCID profiles: Chao Yang, Yingkai Zhang, Tania J Lupoli

Funding

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • New York University
  • U.S. Department of Health and Human Services
  • Arnold and Mabel Beckman Foundation

Cite

APA

Soper, N., Yardumian, I., Chen, E., Yang, C., Ciervo, S., Oom, A. L., Desvignes, L., Mulligan, M. J., Zhang, Y., & Lupoli, T. J. (2024). A Repurposed Drug Interferes with Nucleic Acid to Inhibit the Dual Activities of Coronavirus Nsp13. ACS Chemical Biology. https://doi.org/10.1021/acschembio.4c00244

Vancouver

Soper N, Yardumian I, Chen E, Yang C, Ciervo S, Oom AL, et al. A Repurposed Drug Interferes with Nucleic Acid to Inhibit the Dual Activities of Coronavirus Nsp13. ACS Chemical Biology. 2024. doi:10.1021/acschembio.4c00244

BibTeX
@article{Soper2024,
  author = {Soper, Nathan and Yardumian, Isabelle and Chen, Eric and Yang, Chao and Ciervo, Samantha and Oom, Aaron L and Desvignes, Ludovic and Mulligan, Mark J and Zhang, Yingkai and Lupoli, Tania J},
  title = {A Repurposed Drug Interferes with Nucleic Acid to Inhibit the Dual Activities of Coronavirus Nsp13},
  journal = {ACS Chemical Biology},
  year = {2024},
  doi = {10.1021/acschembio.4c00244}
}
Start for free →